Leverage your data to drive clinical outcomes
Accelerate innovation with real world data
Log in to the OMNY Health Platform
Learn more about OMNY Health
Join our rapidly growing team
Meet our team at upcoming events
Keep up with the latest news
Keep the conversation going
New Studies on the Use of These Medications in Adult and Pediatric Populations are Supported by the Data NetworkAtlanta, Georgia – August 27, 2024 – OMNY Health, the leading healthcare ecosystem known for facilitating compliant cross-industry data partnerships, today...
OMNY Health, the leading healthcare ecosystem known for facilitating compliant cross-industry data sharing launched its platform designed to power AI-driven health technology companies, further cementing the company’s commitment to democratizing healthcare data....
OMNY Health’s GI partnerships are a pivotal step in its mission to deliver data and insights to accelerate life-changing innovation. With a focus on catalyzing research and improving outcomes, OMNY aims to make a tangible difference for the millions of individuals in...
Real-World Data in the Medical Device Market Many life sciences organizations are focused on harnessing real-world data (RWD) capabilities to inform every part of the drug development product life cycle. The same types of RWD can, and should, be applied to innovation...
Recent innovations in healthcare analytics and patient-oriented AI demonstrate the power of leveraging real world data (RWD) to generate ecologically valid actionable insights for life sciences companies to improve patient lives and streamline new therapeutic...
HEOR at the Nexus of Policy and Science OMNY Health believes in the importance of a truly transparent, secure, and connected real-world data (RWD) ecosystem to accelerate life-changing care and treatment innovation between providers, patients, and life science...
On August 31, 2023, the U.S. Food and Drug Administration (FDA) released “Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products: Guidance for Industry.”[1] FDA issued this guidance...
– Collaboration enables provider organizations to deliver de-identified, longitudinal data sets to life science companies and other trial sponsors – – Real-world data offers unique insights in clinical research as drug developers focus on increasing equity in...
Visit the Booth OMNY Health will be presenting and exhibiting at ISPOR Annual on May 7-10, 2023 in Boston, Massachusetts at Booth #1325. Schedule an in-person meeting to learn more about: Clinical measures and social determinants of health data extracted from clinical...
By continuing to use the site, you agree to the use of cookies. More information.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below, then you are consenting to this.